Together, these data suggest that tumor onset in Tg(flk1:RFP)is18 individuals is most likely not due to a loss of function of the lincRNAis18 gene, or disruption of expression of lincRNAis18.v2. The gene discussed is TRGV9; the disease is neoplasm.